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NARROWVERSUSWIDEDIAMETERPORTACAVALH-GRAFTSHUNTS
Sarf eh James, I. andRypins, Eric, B. (1994) Partial versus totalportacavalshunt in alcohofic
cirrhosis. Annals ofSurgery; 219, 353-361.
Objective. Results ofthe first prospective randomized clinical trial comparing partial and total
portacaval shunt for variceal hemorrhage are reported.
Summary BackgroundData. Total portacaval shunts produce subnormal portal pressures,
completely diverting hepatic portal flow. Partial shunts maintain higher pressures and preserve
hepatopedal flow. No randomized trials ofthese two approaches have been performed.
Methods. Alcoholic patients with cirrhosis (n = 30) and variceal hemorrhage treated at one
institution were randomized to receive partial (8-mm diameter portacaval H grafts with
collateral ablation, n = 14) or total shunts (16-mm diameter grafts, n = 16). Portography was
performed after operation and then yearly. Investigators blinded to shunt type assessed
encephalopathy; hospitalizationswere reviewed.
Results. Child’s class, age and operative urgency were similar for thetwo groups.Two patients
(with total shunts) died within30 days. Hepatopedal flowwas maintained in 13 partial and0 total
shunt patients (p < 0.0001). Shunt gradients were 16 + 5 compared with 6 + 3cm saline after
partial and total shunts (p < 0.0001). There were no shunt thromboses or variceal hemorrhages.
Encephalopathy-free survival was significantly greater after partial shunts (p = 0.013; life table
analysis). Five totalcompared with zero partial shunt patients required hospitalization forcoma
(p = 0.02). Long-term survival was not different for the two groups ofpatients.
Conclusions. Partial shunts control variceal hemorrhages while maintaining hepatopedal flow
and elevated portal pressures. By minimizing encephalopathy rates, partial shunts provide
improved quality ofsurvivalcompared with total shunts.
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PAPERDISCUSSION
Partial portal decompression does it really work? This
carefully conducted prospective randomized controlled
trial comparing partial to total portal decompression
presents the most persuasive data yet available that partial
decompression offers a significant advantage compared to
total portal systemic shunt. This study needed to be done,
and the authors are to be commended for a well designed
and carefully executed study I. As two of the majorHPB INTERNATIONAL 209
advocates of partial shunting, Sarfeh and Rypins
recognized the importance of appropriate study design
and elimination ofbias, as far as possible, in settingup this
trial, I believe they have achieved this.
Controlofbleeding. The primary goal ofany treatment for
variceal bleedingmust be to control the bleeding. Data in
this study supports that previously published 2, that a
partial shunt is equally good as a total shunt in control of
bleeding. There was no thrombosis or stenosis in either
group, a factorwhich is particularly pertinent in the era of
transjugular intrahepatic portalsystemic shunts (TIPS).
Stenosis and/or thrombosis is the major problem with
TIPS andmay limit its applicability as bleeding recurs in
these patients.
Encephalopathy. The advantage clearly shown for partial
shunting is a significantly (p < .013) lower rate of
encephalopathy compared to patients receiving total
portal systemic shunts. Let us examine this further.
Who were the patients? All were male, all had alcoholic
cirrhosis, 90% were child’s class A and B, and none had
chronic or spontaneous encephalopathy prior to their
shunts. The two groups were well matched, with the type
ofshunt being the only variable. Did they all stop drinking?
The authors acknowledge that they could not define this
accurately. This variable may have had some influence,
but it is reasonable to assume was not significantly
different between groups.
How were patients managed? Diet was not restricted in
either group, nor were specific medications used
prophylactically to reduce the risk ofencephalopathy. For
the purpose of this study this was an appropriate design
when comparison between the two groups was the goal.
No data are given as to whether protein intake was indeed
equivalent between the two groups: unrestricted dietmay
not equate to equivalency! Other potential precipitants of
encephalopathy, such as gastrointestinal bleeding, and
infection do not appear different between groups. The
greater diuretic requirement in the partial shunt groupwas
a possible adverse factor in that group, but did not
translate into a higher rate ofencephalopathy.
How was encephalopathy assessed? This is always one
ofthe most difficult design factors in a study such as this.
The authors chose to use two endpoints, i) a "functional"
encephalopathy measure, and ii) the need for
rehospitalization. The differences between the two shunt
groups is very clear by any index used, and the 57%
incidence of moderate to severe encephalopathy in the
total shunt group compared to 14% in the partial shunt
group is the most compelling data in this study. Use of
other tests of encephalopathy such as EEG or
psychometric evaluation might be sought by some purists,
but are unlikely to have altered this finding.
In parallel with prior data from this group 2, the low
encephalopathy rate in the partial shunt group is
associated with good maintenance ofportal perfusion to
the liver. Unfortunately, less than 50% of patients had
hemodynamic studies at late follow up, whichweakens the
conclusions for the hemodynamic/encephalopathy
correlation at that time.
Other endpo&ts. Ascites was significantly higher in the
partial shunt group. This is not surprising as portal
pressure was not reduced as much in this group. This
finding does raise the question as to why a greater portal
pressure reduction is required to control ascites than
bleeding in portal hypertension?
Survival was not significantly different between the two
groups at 20 months. Longer term followup in this study is
important to document if the markedly lower
encephalopathy ofthe partial shunt group will ultimately
be associated with better survival.
Where does partial shunting fit in the total scheme of
management?
In the 1990s, most would agree there is no single best
way to manage all patients with variceal bleeding. The
range of options for such patients now goes from
pharmacologic portal pressure reduction, to
sclerotherapy, radiologic shunts, total, partial or selective
operative decompression, devascularization, all theway to
liver transplantation. Better understanding of the
underlying diseases and their natural history, oftherapies
and their natural history, and an ability to match patients
to their appropriate therapy is the key in the 1990’s. The
data in this paper provide useful information in defining a
role for partial systemic shunt.
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